HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gregory J Dore Selected Research

Liver Transplantation

11/2021Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics.
10/2017Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014).
10/2009The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006.
3/2005Estimation of utilities for chronic hepatitis C from SF-36 scores.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gregory J Dore Research Topics

Disease

150Infections
04/2024 - 05/2000
59Hepatitis C
04/2024 - 07/2005
36Fibrosis (Cirrhosis)
05/2022 - 03/2005
32Coinfection
12/2023 - 10/2003
29Reinfection
04/2024 - 10/2009
29Chronic Hepatitis C
01/2022 - 10/2003
22Liver Diseases (Liver Disease)
02/2024 - 12/2007
12Hepatitis B
03/2024 - 07/2004
11COVID-19
03/2024 - 01/2021
10Hepatocellular Carcinoma (Hepatoma)
12/2023 - 03/2005
10HIV Infections (HIV Infection)
02/2016 - 12/2003
9Hepatitis
10/2023 - 05/2004
8Disease Progression
01/2019 - 10/2003
5Liver Cirrhosis (Hepatic Cirrhosis)
10/2019 - 09/2008
5Acquired Immunodeficiency Syndrome (AIDS)
01/2011 - 04/2002
4Substance-Related Disorders (Drug Abuse)
05/2023 - 01/2021
4Persistent Infection
01/2023 - 09/2014
4Blister (Bulla)
10/2020 - 01/2018
4Viremia
01/2019 - 10/2010
3Chronic Hepatitis B
12/2020 - 01/2010
3Virus Diseases (Viral Diseases)
01/2020 - 09/2011
2Opioid-Related Disorders (Opiate Addiction)
03/2024 - 01/2022
2Cognitive Dysfunction
01/2024 - 01/2023
2Communicable Diseases (Infectious Diseases)
12/2021 - 01/2018
2Nausea
12/2018 - 01/2017
2Headache (Headaches)
01/2017 - 08/2014
2Fatigue
01/2017 - 08/2014
2Anemia
06/2014 - 04/2011
2Neoplasms (Cancer)
12/2012 - 05/2009
2Superinfection
04/2012 - 11/2010
2AIDS Dementia Complex
07/2003 - 04/2002
1Tetanus
03/2024
1Hepatitis A (Hepatitis, Infectious)
03/2024
1Pneumococcal Infections
03/2024
1Human Influenza (Influenza)
03/2024

Drug/Important Bio-Agent (IBA)

83Antiviral Agents (Antivirals)IBA
02/2024 - 10/2003
44RNA (Ribonucleic Acid)IBA
04/2024 - 05/2004
40InterferonsIBA
01/2023 - 03/2005
31Ribavirin (Virazole)FDA LinkGeneric
10/2020 - 07/2007
17Opioid Analgesics (Opioids)IBA
11/2023 - 07/2007
16VaccinesIBA
03/2024 - 03/2007
15SofosbuvirIBA
10/2021 - 08/2015
9AntigensIBA
04/2024 - 01/2007
9Alanine Transaminase (SGPT)IBA
10/2023 - 04/2007
9velpatasvirIBA
10/2021 - 12/2015
7glecaprevir and pibrentasvirIBA
10/2023 - 01/2017
6daclatasvirIBA
10/2019 - 02/2015
6peginterferon alfa-2a (Pegasys)FDA Link
02/2015 - 07/2007
5Protease Inhibitors (Protease Inhibitor)IBA
01/2017 - 11/2011
5Proteins (Proteins, Gene)FDA Link
05/2016 - 05/2000
5CytokinesIBA
02/2016 - 11/2012
5Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2014 - 06/2004
5Tenofovir (Viread)FDA Link
05/2013 - 01/2007
5Hepatitis B e AntigensIBA
01/2013 - 01/2007
4DNA (Deoxyribonucleic Acid)IBA
12/2023 - 04/2008
4Interferon LambdaIBA
01/2022 - 11/2014
4telaprevirIBA
01/2016 - 11/2011
4Heroin (Diamorphine)IBA
10/2014 - 01/2014
3Hepatitis C AntibodiesIBA
04/2024 - 10/2010
3Biomarkers (Surrogate Marker)IBA
01/2024 - 06/2012
3EnzymesIBA
01/2023 - 11/2012
3ombitasvirIBA
10/2020 - 11/2018
3dasabuvirIBA
10/2020 - 11/2018
3paritaprevirIBA
10/2020 - 11/2018
3Ritonavir (Norvir)FDA Link
10/2020 - 11/2018
3sofosbuvir drug combination ledipasvirIBA
01/2018 - 12/2016
3Interferon-gamma (Interferon, gamma)IBA
01/2016 - 01/2013
3Interferon-alpha (Interferon Alfa)IBA
10/2014 - 10/2009
3Lamivudine (Epivir)FDA Link
01/2010 - 01/2007
2Immunoglobulin G (IgG)IBA
04/2024 - 08/2022
2Buprenorphine (Subutex)FDA LinkGeneric
03/2024 - 01/2022
2Illicit Drugs (Recreational Drugs)IBA
02/2024 - 01/2017
2nafamostatIBA
11/2023 - 10/2022
2Methamphetamine (Desoxyn)FDA LinkGeneric
01/2023 - 01/2014
2sofosbuvir velpatasvir voxilaprevir drug combinationIBA
05/2022 - 01/2017
2Indicators and Reagents (Reagents)IBA
01/2022 - 11/2017
2grazoprevirIBA
06/2020 - 11/2016
2elbasvirIBA
06/2020 - 11/2016
2glecaprevirIBA
01/2018 - 01/2017
2pibrentasvirIBA
01/2018 - 01/2017
2NucleotidesIBA
01/2017 - 05/2016
2ChemokinesIBA
02/2016 - 01/2016
2Interleukin-6 (Interleukin 6)IBA
01/2016 - 09/2014
2LipidsIBA
01/2016 - 03/2010
2Transaminases (Aminotransferases)IBA
01/2016 - 12/2013
2N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
08/2014 - 11/2011
2SimeprevirIBA
08/2014 - 12/2013
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2014 - 06/2012
2RacivirIBA
01/2010 - 08/2009

Therapy/Procedure

100Therapeutics
02/2024 - 10/2003
17Opiate Substitution Treatment
01/2022 - 07/2005
9Highly Active Antiretroviral Therapy (HAART)
01/2013 - 04/2002
8Retreatment
02/2024 - 11/2017
4Injections
03/2024 - 01/2021
4Liver Transplantation
11/2021 - 03/2005
4Duration of Therapy
12/2016 - 03/2011
2Aftercare (After-Treatment)
01/2022 - 01/2022
2Ambulatory Care (Outpatient Care)
01/2020 - 04/2011
2Drug Therapy (Chemotherapy)
10/2015 - 07/2007
2Tattooing
10/2010 - 09/2007